Therapeutic Drug Monitoring (TDM) is a crucial aspect of optimizing the efficacy and safety of antimicrobial therapy. Antimicrobial agents play a pivotal role in treating bacterial, fungal, and viral infections, and TDM provides a systematic approach to ensuring their therapeutic levels are maintained within a narrow range. TDM involves measuring drug concentrations in a patient's blood or other biological fluids to individualize the dosage and achieve the desired therapeutic effect. For antimicrobials, TDM is particularly relevant due to the narrow therapeutic window and interpatient variability in drug pharmacokinetics. This monitoring helps healthcare professionals make informed decisions regarding dose adjustments, ensuring optimal drug exposure while minimizing the risk of toxicity. Factors influencing the need for TDM in antimicrobial therapy include patient-specific factors (age, renal and hepatic function), drug characteristics (pharmacokinetics, pharmacodynamics), and the nature of the infection being treated. In critically ill patients, those with compromised renal function, or those receiving multiple medications, TDM becomes even more crucial to prevent suboptimal dosing or toxicity. TDM aids in addressing challenges such as bacterial resistance and the emergence of multidrug-resistant strains. By optimizing antimicrobial dosages, TDM contributes to reducing the development of resistance, ensuring that a sufficient concentration of the drug is maintained to eradicate the pathogen effectively.